81a56b55_Biosafety__otes___Specific_Considerations
[NIH Subcategory] D-2 Experiments in which DNAfrom Risk Group 2, Risk Group 3, Risk Group 4 or restricted agents is cloned into non-pathogenicprokaryotic or lower eukaryotic host-vector systems.
When cloning is from Risk Group 2 or 3 pathogens, BL2 containment is generally prescribed, but specific lowering to BL1 may be approved by IBC.
Biosafety
Notes & Specific Considerations